经常下调业绩又上调业_老虎社区_美港股上老虎 - 老虎社区

经常下调业绩又上调业绩，你耍猴呀

诺和诺德Q1净利润及明星减肥药销量均高于预期，上调2026年业绩展望

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

1

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":561305327731664,"tweetId":"561305327731664","gmtCreate":1778069133146,"gmtModify":1778069135696,"author":{"id":3493844916413110,"idStr":"3493844916413110","authorId":3493844916413110,"authorIdStr":"3493844916413110","name":"风石康俊","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":0,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body><p>经常下调业绩又上调业绩，你耍猴呀</p></body></html>","htmlText":"<html><head></head><body><p>经常下调业绩又上调业绩，你耍猴呀</p></body></html>","text":"经常下调业绩又上调业绩，你耍猴呀","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/561305327731664","repostId":2633590349,"repostType":2,"repost":{"id":"2633590349","kind":"live","weMediaInfo":{"introduction":"港股挖掘机将每天为您推送最具价值的港股、美股、A股投资资讯！第一时间把握全球政策动向，先人一步了解主流资金流向，监测主力行踪，解读公司公告，追踪活跃个股，让您畅享投资财富盛宴!","home_visible":1,"media_name":"智通财经APP","id":"12","head_image":"https://static.tigerbbs.com/361f7f1ca0d64e919035653d64c723ab"},"pubTimestamp":1778045486,"share":"https://www.laohu8.com/m/news/2633590349?lang=zh_CN&edition=full","pubTime":"2026-05-06 13:31","market":"us","language":"zh","title":"诺和诺德Q1净利润及明星减肥药销量均高于预期，上调2026年业绩展望","url":"https://stock-news.laohu8.com/highlight/detail?id=2633590349","media":"智通财经APP","summary":"预计全球GLP-1市场将持续扩张。","content":"<html><head></head><body><p><a href=\"https://laohu8.com/S/NVO\">诺和诺德</a> 第一季度净销售额为968.23亿丹麦克朗，同比增长24%；净利润为485.57亿丹麦克朗，同比增长67%，高于预期的234.9亿丹麦克朗。</p><p>第一季度减肥明星药物Wegovy销售额为182.35亿丹麦克朗，市场预估为173.96亿丹麦克朗。</p><p style=\"text-align: justify;\">诺和诺德上调2026年业绩预期，预计全年调整后销售额将同比下降4%至12%，此前预期为同比下降5%至13%。预计全球GLP-1市场将持续扩张。</p><p>诺和诺德夜盘股价拉升，涨超4%。</p><p></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/8a87e4e634601b504e357c969ed514d4\" tg-width=\"1305\" tg-height=\"507\"/></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1d2e550d0cc5e5b51107710ea2d175c8\" alt=\"\" title=\"\" tg-width=\"890\" tg-height=\"1061\"/></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>诺和诺德Q1净利润及明星减肥药销量均高于预期，上调2026年业绩展望</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n诺和诺德Q1净利润及明星减肥药销量均高于预期，上调2026年业绩展望\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/12\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/361f7f1ca0d64e919035653d64c723ab);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">智通财经APP </p>\n<p class=\"h-time\">2026-05-06 13:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p><a href=\"https://laohu8.com/S/NVO\">诺和诺德</a> 第一季度净销售额为968.23亿丹麦克朗，同比增长24%；净利润为485.57亿丹麦克朗，同比增长67%，高于预期的234.9亿丹麦克朗。</p><p>第一季度减肥明星药物Wegovy销售额为182.35亿丹麦克朗，市场预估为173.96亿丹麦克朗。</p><p style=\"text-align: justify;\">诺和诺德上调2026年业绩预期，预计全年调整后销售额将同比下降4%至12%，此前预期为同比下降5%至13%。预计全球GLP-1市场将持续扩张。</p><p>诺和诺德夜盘股价拉升，涨超4%。</p><p></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/8a87e4e634601b504e357c969ed514d4\" tg-width=\"1305\" tg-height=\"507\"/></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1d2e550d0cc5e5b51107710ea2d175c8\" alt=\"\" title=\"\" tg-width=\"890\" tg-height=\"1061\"/></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/257a3e30cbff798890dbfcb71b0e7f1e","relate_stocks":{"NVOX":"2倍做多NVO ETF-Defiance","NVO":"诺和诺德","NVOH":"Novo Nordisk A/S B Shares ADRhedged"},"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2633590349","content_text":"诺和诺德 第一季度净销售额为968.23亿丹麦克朗，同比增长24%；净利润为485.57亿丹麦克朗，同比增长67%，高于预期的234.9亿丹麦克朗。第一季度减肥明星药物Wegovy销售额为182.35亿丹麦克朗，市场预估为173.96亿丹麦克朗。诺和诺德上调2026年业绩预期，预计全年调整后销售额将同比下降4%至12%，此前预期为同比下降5%至13%。预计全球GLP-1市场将持续扩张。诺和诺德夜盘股价拉升，涨超4%。","news_type":1,"symbols_score_info":{"NVOX":0.6,"NVO":2,"NVOH":0.6}},"isVote":1,"tweetType":1,"viewCount":22,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":31,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/561305327731664"}